JP2004507511A5 - - Google Patents

Download PDF

Info

Publication number
JP2004507511A5
JP2004507511A5 JP2002522940A JP2002522940A JP2004507511A5 JP 2004507511 A5 JP2004507511 A5 JP 2004507511A5 JP 2002522940 A JP2002522940 A JP 2002522940A JP 2002522940 A JP2002522940 A JP 2002522940A JP 2004507511 A5 JP2004507511 A5 JP 2004507511A5
Authority
JP
Japan
Prior art keywords
gel according
ethanol
weight
hydroalcohol
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002522940A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004507511A (ja
Filing date
Publication date
Priority claimed from US09/651,777 external-priority patent/US6503894B1/en
Application filed filed Critical
Priority claimed from PCT/US2001/027199 external-priority patent/WO2002017967A1/en
Publication of JP2004507511A publication Critical patent/JP2004507511A/ja
Publication of JP2004507511A5 publication Critical patent/JP2004507511A5/ja
Pending legal-status Critical Current

Links

JP2002522940A 2000-08-30 2001-08-29 女性におけるテストステロンおよび近縁ステロイド濃度を増大させる方法 Pending JP2004507511A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/651,777 US6503894B1 (en) 2000-08-30 2000-08-30 Pharmaceutical composition and method for treating hypogonadism
US70375300A 2000-11-01 2000-11-01
US29239801P 2001-05-21 2001-05-21
PCT/US2001/027199 WO2002017967A1 (en) 2000-08-30 2001-08-29 Method of increasing testosterone and related steroid concentrations in women

Publications (2)

Publication Number Publication Date
JP2004507511A JP2004507511A (ja) 2004-03-11
JP2004507511A5 true JP2004507511A5 (enExample) 2008-10-16

Family

ID=27404127

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002522940A Pending JP2004507511A (ja) 2000-08-30 2001-08-29 女性におけるテストステロンおよび近縁ステロイド濃度を増大させる方法

Country Status (16)

Country Link
EP (1) EP1322336B1 (enExample)
JP (1) JP2004507511A (enExample)
KR (1) KR20030048021A (enExample)
CN (1) CN100349572C (enExample)
AU (2) AU8536701A (enExample)
BR (1) BR0113649A (enExample)
CA (1) CA2419573C (enExample)
DK (1) DK1322336T3 (enExample)
ES (1) ES2423899T3 (enExample)
IL (2) IL154693A0 (enExample)
MX (1) MXPA03001859A (enExample)
NO (1) NO334991B1 (enExample)
NZ (1) NZ536633A (enExample)
PL (1) PL360992A1 (enExample)
PT (1) PT1322336E (enExample)
WO (1) WO2002017967A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN814496A0 (en) 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
CA2418135C (en) 2000-08-03 2011-09-20 Antares Pharma Ipl Ag Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030027804A1 (en) * 2001-06-27 2003-02-06 Van Der Hoop Roland Gerritsen Therapeutic combinations for the treatment of hormone deficiencies
MXPA04008988A (es) * 2002-03-15 2006-05-25 Unimed Pharmaceuticals Inc Composicion androgena farmaceutica y metodo para el tratamiento de la depresion.
BR0308584A (pt) * 2002-03-15 2005-02-22 Unimed Pharmaceuticals Inc Composição farmacêutica androgênica e método para tratamento de depressão
MY139721A (en) * 2002-04-19 2009-10-30 Cpex Pharmaceuticals Inc Pharmaceutical composition
WO2004000263A1 (en) 2002-06-25 2003-12-31 Acrux Dds Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
AUPS317302A0 (en) * 2002-06-25 2002-07-18 Drug Delivery Solutions Pty Ltd Metastable pharmaceutical compositions
AU2003240299B2 (en) * 2002-06-25 2008-01-31 Acrux Dds Pty. Ltd. Metastable pharmaceutical compositions
US8883769B2 (en) 2003-06-18 2014-11-11 White Mountain Pharma, Inc. Methods for the treatment of fibromyalgia and chronic fatigue syndrome
US20040259852A1 (en) * 2003-06-18 2004-12-23 White Hillary D. Trandsdermal compositions and methods for treatment of fibromyalgia and chronic fatigue syndrome
CA2538856C (en) 2003-10-10 2010-06-29 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues
GB0409498D0 (en) * 2004-04-28 2004-06-02 Hunter Fleming Ltd Transdermal steroid formulation
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
AU2006235453A1 (en) * 2005-04-12 2006-10-19 Laboratories Besins International Method of treating or preventing bone deterioration or osteoporosis
KR20080016552A (ko) * 2005-04-13 2008-02-21 유니메드 파마슈티칼스, 인크. 여성의 테스토스테론 및 관련된 스테로이드의 농도를증가시키는 방법
WO2007124250A2 (en) 2006-04-21 2007-11-01 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2006125642A1 (en) * 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
KR20130114229A (ko) 2005-06-03 2013-10-16 애크럭스 디디에스 피티와이 리미티드 경피 약물 전달 방법 및 조성물
EP1896038B1 (en) * 2005-06-03 2016-11-09 Acrux DDS Pty Ltd Method and composition for testosterone transdermal delivery
RS52671B (sr) 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc Poboljšani gel testosterona i postupak korišćenja
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
PH12012500882A1 (en) 2009-12-23 2013-01-07 Colgate Palmolive Co Oral care system, kit and method
BR112012015730A2 (pt) 2009-12-23 2021-07-06 Colgate Palmolive Co sistema de tratamento bucal.
KR101528395B1 (ko) 2009-12-23 2015-06-11 콜게이트-파아므올리브캄파니 구강 관리 시스템
KR101513342B1 (ko) 2009-12-23 2015-04-17 콜게이트-파아므올리브캄파니 구강 관리 시스템
US9642862B2 (en) 2010-11-18 2017-05-09 White Mountain Pharma, Inc. Methods for treating chronic or unresolvable pain and/or increasing the pain threshold in a subject and pharmaceutical compositions for use therein
US12186326B2 (en) 2018-07-05 2025-01-07 Celista Pharmaceuticals Llc Testosterone and estradiol transdermal spray
AU2021216630A1 (en) 2020-02-05 2022-09-22 Neurocrine UK Limited Testosterone containing pharmaceutical composition
CN115754070B (zh) * 2022-11-24 2025-11-25 深圳市第二人民医院(深圳市转化医学研究院) 同时测定血液中总睾酮和游离睾酮含量的方法及试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496556A (en) * 1982-08-16 1985-01-29 Norman Orentreich Topical applications for preventing dry skin
US5152997A (en) * 1990-12-11 1992-10-06 Theratech, Inc. Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels
US5776923A (en) * 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
PT1382340E (pt) * 1993-01-19 2006-07-31 Endorech Inc Utilizacoes terapeuticas de desidroepiandrosterona para tratar libido diminuida e osteoporose
US6007837A (en) * 1996-07-03 1999-12-28 Alza Corporation Drug delivery devices and process of manufacture
DE19701949A1 (de) * 1997-01-13 1998-07-16 Jenapharm Gmbh Transdermales therapeutisches System
KR20000070757A (ko) * 1997-02-07 2000-11-25 에버트 챨스 디 테스토스테론 결핍증이 나타나는 여성에게 테스토스테론을 보충하는 방법 및 이에 이용되는 조성물
US5968919A (en) * 1997-10-16 1999-10-19 Macrochem Corporation Hormone replacement therapy drug formulations for topical application to the skin
CA2309688C (en) * 1997-11-10 2007-04-24 Cellegy Pharmaceuticals, Inc. Penetration enhancing and irritation reducing systems

Similar Documents

Publication Publication Date Title
IL154693A (en) Use of testosterone gel to make a remedy for testosterone deficiency in women
JP2004524267A5 (enExample)
EP0335115B1 (fr) Compositions pharmaceutiques et cosmétiques à base de peroxyde de benzoyle et de sels d'ammonium quaternaires
RU2004106779A (ru) Способ профилактики и/или лечения дисфункции и/или нарушения структуры ногтей, пластырь для его осуществления и его применение
CA2147806C (fr) Composes polyeniques, compositions pharmaceutiques et cosmetiques les contenant et utilisations
EP2039355A3 (en) Topical use of valproic acid for the prevention or treatment of skin disorders
FR2623395A1 (fr) Compositions pharmaceutiques et cosmetiques a base de peroxyde de benzoyle et de salicylates lipophiles d'ammonium quaternaires et leur utilisation, notamment dans le traitement de l'acne
DE69720985D1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
JP2000514050A (ja) 防虫日焼け止め剤組成物
JP2001520998A5 (enExample)
JP4597273B2 (ja) 経口組成物
JP2002518502A5 (enExample)
ES2188426A1 (es) Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias.
JP2024542943A5 (enExample)
CA2448829C (en) Preparation for the removal of abnormal keratinous material
JP2003521505A5 (enExample)
JPH04504562A (ja) 皮膚疾患及び腫瘍の処理のための製剤
JP2002520281A5 (enExample)
GB2205239A (en) Infrared blocker
CA2464420A1 (en) Dosage unit comprising a prostaglandin analog for treating constipation
FR2746098A1 (fr) Composes propynyl biaromatiques
JP2920443B2 (ja) 角栓除去剤
CA2291650C (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
AU2173101A (en) Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
JP2000507248A (ja) ざ瘡（にきび）治療